| [1] |
Blann A. What is the purpose of liver function tests?[J]. Nurs Times, 2014, 110(6): 17-19.
|
| [2] |
Wang Y Y, Zhao X H, Ma L, et al. Comparison of the ability of Child-Pugh score, MELD score, and ICG-R15 to assess preoperative hepatic functional reserve in patients with hepatocellular carcinoma[J]. J Surg Oncol, 2018, 118(3): 440-445.
|
| [3] |
Demirtas C O, D'Alessio A, Rimassa L, et al. ALBI grade: Evidence for an improved model for liver functional estimation in patients with hepatocellular carcinoma[J]. JHEP Rep, 2021, 3(5): 100347.
|
| [4] |
刘磊, 韩涛, 聂彩云, 等. 13C-美沙西丁呼气试验在评价慢加急性肝衰竭患者肝储备功能及预后中的应用:第7届全国疑难及重症肝病大会[C]. 北京, 2013.
|
| [5] |
Fernández-Placencia R, Golse N, Cano L, et al. Spleen volumetry and liver transient elastography: Predictors of persistent posthepatectomy decompensation in patients with hepatocellular carcinoma[J]. Surgery, 2020, 168(1): 17-24.
|
| [6] |
Wong JS, Wong GL, Chan AW, et al. Liver stiffness measurement by transient elastography as a predictor on posthepatectomy outcomes[J]. Ann Surg, 2013, 257(5): 922-928.
|
| [7] |
Cescon M, Colecchia A, Cucchetti A, et al. Value of transient elastography measured with FibroScan in predicting the outcome of hepatic resection for hepatocellular carcinoma[J]. Ann Surg, 2012, 256(5): 706-713.
|
| [8] |
秦响, 张建东, 孔丹, 等. 肝脏占位CT虚拟成像中残余肝体积在肝脏储备功能评估的价值[J]. 实用医学杂志, 2022, 38(22): 2845-2849.
|
| [9] |
黄涛. 肝脏体积CT测量预测肝癌术后肝功能损害的临床研究[D]. 杭州: 浙江大学, 2006.
|
| [10] |
Beppu T, Hayashi H, Okabe H, et al. Liver functional volumetry for portal vein embolization using a newly developed 99mTc-galactosyl human serum albumin scintigraphy SPECT-computed tomography fusion system[J]. J Gastroenterol, 2011, 46(7): 938-943.
|
| [11] |
Sumiyoshi T, Shima Y, Okabayashi T, et al. Functional discrepancy between two liver lobes after hemilobe biliary drainage in patients with jaundice and bile duct cancer: an appraisal using(99m)Tc-GSA SPECT/CT fusion imaging[J]. Radiology, 2014, 273(2): 444-451.
|
| [12] |
Döhr O, Hofmeister R, Treher M, et al. Preclinical safety evaluation of Gd-EOB-DTPA(Primovist)[J]. Invest Radiol, 2007, 42(12): 830-841.
|
| [13] |
Van Kessel CS, de Boer E, Ten KF, et al. Focal nodular hyperplasia: hepatobiliary enhancement patterns on gadoxetic-acid contrast- enhanced MRI[J]. Abdom Imaging, 2013, 38(3): 490-501.
|
| [14] |
Gschwend S, Ebert W, Schultze-Mosgau M, et al. Pharmacokinetics and imaging properties of Gd-EOB-DTPA in patients with hepatic and renal impairment[J]. Invest Radiol, 2011, 46(9): 556-566.
|
| [15] |
Kim YC, Kim MJ, Park YN, et al. Relationship between severity of liver dysfunction and the relative ratio of liver to aortic enhancement(RE) on MRI using hepatocyte-specific contrast[J]. J Magn Reson Imaging, 2014, 39(1): 24-30.
|
| [16] |
Besa C, Bane O, Jajamovich G, et al. 3D T1 relaxometry pre and post gadoxetic acid injection for the assessment of liver cirrhosis and liver function[J]. Magn Reson Imaging, 2015, 33(9): 1075-1082.
|
| [17] |
Feng ST, Wu L, Chan T, et al. Functional magnetic resonance cholangiography enhanced with Gd-EOB-DTPA: effect of liver function on biliary system visualization[J]. J Magn Reson Imaging, 2014, 39(5): 1254-1258.
|
| [18] |
Shi Z, Cai W, Feng X, et al. Radiomics Analysis of Gd-EOB-DTPA Enhanced Hepatic MRI for Assessment of Functional Liver Reserve[J]. Acad Radiol, 2022, 29(2): 213-218.
|
| [19] |
Bastati N, Wibmer A, Tamandl D, et al. Assessment of Orthotopic Liver Transplant Graft Survival on Gadoxetic Acid-Enhanced Magnetic Resonance Imaging Using Qualitative and Quantitative Parameters[J]. Invest Radiol, 2016, 51(11): 728-734.
|
| [20] |
Chundru S, Kalb B, Arif-Tiwari H, et al. MRI of diffuse liver disease: characteristics of acute and chronic diseases[J]. Diagn Interv Radiol, 2014, 20(3): 200-208.
|
| [21] |
Koppe SW. Obesity and the liver: nonalcoholic fatty liver disease[J]. Transl Res, 2014, 164(4): 312-322.
|
| [22] |
Tsuda N, Okada M, Murakami T. Potential of gadolinium- ethoxybenzyl-diethylenetriamine pentaacetic acid(Gd-EOB-DTPA) for differential diagnosis of nonalcoholic steatohepatitis and fatty liver in rats using magnetic resonance imaging[J]. Invest Radiol, 2007, 42(4): 242-247.
|
| [23] |
Yamada T, Obata A, Kashiwagi Y, et al. Gd-EOB-DTPA-enhanced- MR imaging in the inflammation stage of nonalcoholic steatohepatitis (NASH) in mice[J]. Magn Reson Imaging, 2016, 34(6): 724-729.
|
| [24] |
Yamada T, Kashiwagi Y, Rokugawa T, et al. Evaluation of hepatic function using dynamic contrast-enhanced magnetic resonance imaging in melanocortin 4 receptor-deficient mice as a model of nonalcoholic steatohepatitis[J]. Magn Reson Imaging, 2019, 57: 210-217.
|
| [25] |
Ding Y, Rao S X, Meng T, et al. Usefulness of T1 mapping on Gd-EOB-DTPA-enhanced MR imaging in assessment of non-alcoholic fatty liver disease[J]. Eur Radiol, 2014, 24(4): 959-966.
|
| [26] |
Xie Y, Zhang H, Jin C, et al. Gd-EOB-DTPA-enhanced T1ρ imaging vs diffusion metrics for assessment liver inflammation and early stage fibrosis of nonalcoholic steatohepatitis in rabbits[J]. Magn Reson Imaging, 2018, 48: 34-41.
|
| [27] |
丁莺, 曾蒙苏, 饶圣祥, 等. 肝细胞特异性对比剂钆塞酸二钠增强磁共振检查对非酒精性脂肪肝诊断及分级的潜在价值[J]. 中华肝脏病杂志, 2015, 23(4): 297-299.
|
| [28] |
Onishi H, Theisen D, Dietrich O, et al. Hepatic steatosis: effect on hepatocyte enhancement with gadoxetate disodium-enhanced liver MR imaging[J]. J Magn Reson Imaging, 2014, 39(1): 42-50.
|
| [29] |
Yeom SK, Byun JH, Kim HJ, et al. Focal fat deposition at liver MRI with gadobenate dimeglumine and gadoxetic acid: quantitative and qualitative analysis[J]. Magn Reson Imaging, 2013, 31(6): 911-917.
|
| [30] |
李满彪, 李金玉, 冯对平. 肝纤维化逆转的研究进展[J]. 临床肝胆病杂志, 2023, 39(1): 193-198.
|
| [31] |
Verloh N, Utpatel K, Haimerl M, et al. Detecting liver fibrosis with Gd-EOB-DTPA-enhanced MRI: A confirmatory study[J]. Sci Rep, 2018, 8(1): 6207.
|
| [32] |
Harada TL, Saito K, Araki Y, et al. Prediction of high-stage liver fibrosis using ADC value on diffusion-weighted imaging and quantitative enhancement ratio at the hepatobiliary phase of Gd-EOB-DTPA-enhanced MRI at 1. 5 T[J]. Acta Radiol, 2018, 59(5): 509-516.
|
| [33] |
师丹丹, 郭然, 刘月华, 等. 钆塞酸二钠增强MRI定量评估肝纤维化的价值[J]. 中华放射学杂志, 2022, 56(3): 273-278.
|
| [34] |
Kamimura K, Fukukura Y, Yoneyama T, et al. Quantitative evaluation of liver function with T1 relaxation time index on Gd-EOB-DTPA- enhanced MRI: comparison with signal intensity-based indices[J]. J Magn Reson Imaging, 2014, 40(4): 884-889.
|
| [35] |
Haimerl M, Utpatel K, Verloh N, et al. Gd-EOB-DTPA-enhanced MR relaxometry for the detection and staging of liver fibrosis[J]. Sci Rep, 2017, 7: 41429.
|
| [36] |
Sheng RF, Wang HQ, Yang L, et al. Assessment of liver fibrosis using T1 mapping on Gd-EOB-DTPA-enhanced magnetic resonance[J]. Dig Liver Dis, 2017, 49(7): 789-795.
|
| [37] |
Yasaka K, Akai H, Kunimatsu A, et al. Liver Fibrosis: Deep Convolutional Neural Network for Staging by Using Gadoxetic Acid-enhanced Hepatobiliary Phase MR Images[J]. Radiology, 2018, 287(1): 146-155.
|
| [38] |
Park HJ, Lee SS, Park B, et al. Radiomics Analysis of Gadoxetic Acid-enhanced MRI for Staging Liver Fibrosis[J]. Radiology, 2019, 290(2): 380-387.
|
| [39] |
Yang M, Zhang Y, Zhao W, et al. Evaluation of liver function using liver parenchyma, spleen and portal vein signal intensities during the hepatobiliary phase in Gd-EOB-D TPA-enhanced MRI[J]. BMC Med Imaging, 2020, 20(1): 119.
|
| [40] |
Wang Q, Kesen S, Liljeroth M, et al. Quantitative evaluation of liver function with gadoxetic acid enhanced MRI: Comparison among signal intensity-, T1-relaxometry-, and dynamic-hepatocyte-specific- contrast-enhanced MRI- derived parameters[J]. Scand J Gastroenterol, 2022: 1-8.
|
| [41] |
Öcal O, Peynircioglu B, Loewe C, et al. Correlation of liver enhancement in gadoxetic acid-enhanced MRI with liver functions: a multicenter-multivendor analysis of hepatocellular carcinoma patients from SORAMIC trial[J]. Eur Radiol, 2022, 32(2): 1320-1329.
|
| [42] |
Mori H, Machimura H, Iwaya A, et al. Comparison of liver scintigraphy and the liver-spleen contrast in Gd-EOB-DTPA- enhanced MRI on liver function tests[J]. Sci Rep, 2021, 11(1): 22472.
|
| [43] |
李晨霞, 刘海甜, 李香, 等. 钆塞酸二钠增强MRI在评估肝功能中的参数选择研究[J]. 中华实用诊断与治疗杂志, 2019, 33(12): 1212-1216.
|
| [44] |
毕新军, 张学琴, 陆健, 等. 钆塞酸二钠增强MRI肝细胞摄取定量参数评估肝功能[J]. 放射学实践, 2021, 36(4): 514-519.
|
| [45] |
Katsube T, Okada M, Kumano S, et al. Estimation of liver function using T1 mapping on Gd-EOB-DTPA-enhanced magnetic resonance imaging[J]. Invest Radiol, 2011, 46(4): 277-283.
|
| [46] |
Obmann VC, Catucci D, Berzigotti A, et al. T1 reduction rate with Gd-EOB-DTPA determines liver function on both 1. 5 T and 3 T MRI[J]. Sci Rep, 2022, 12(1): 4716.
|
| [47] |
Shi Z, Cai W, Feng X, et al. Radiomics Analysis of Gd-EOB-DTPA Enhanced Hepatic MRI for Assessment of Functional Liver Reserve[J]. Acad Radiol, 2022, 29(2): 213-218.
|
| [48] |
周玮, 胡红杰, 沈博, 等. 基于钆塞酸二钠增强磁共振成像影像组学定量评估肝硬化患者肝脏储备功能的应用价值[J]. 中国医学科学院学报, 2020, 42(4): 459-467.
|
| [49] |
黄茗勇, 周军, 王展. Gd-EOB-DTPA增强MR胆管成像对乙肝肝硬化患者的诊断价值[J]. 海南医学, 2022, 33(18): 2403-2406.
|
| [50] |
Tang G, Liu J, Liu P, et al. Evaluation of liver function in patients with liver cirrhosis and chronic liver disease using functional liver imaging scores at different acquisition time points[J]. Front Genet, 2022, 13: 1071025.
|
| [51] |
Aslan S, Eryuruk U, Tasdemir MN, et al. Determining the efficacy of functional liver imaging score(FLIS) obtained from gadoxetic acid-enhanced MRI in patients with chronic liver disease and liver cirrhosis: the relationship between Albumin-Bilirubin(ALBI) grade and FLIS[J]. Abdom Radiol(NY), 2022, 47(7): 2325-2334.
|
| [52] |
杜艳妮, 吕志彬, 关春爽, 等. 钆塞酸二钠增强MRI功能性肝脏影像评分影像征象与Child-Turcotte-Pugh分级评估肝功能的对照研究[J]. 临床放射学杂志, 2021, 40(11): 2134-2138.
|
| [53] |
李长峰, 王强, 瞿成名, 等. 基于Gd-EOB-DTPA增强MRI的列线图模型在预测肝肿瘤术后肝衰竭中的临床价值[J]. 中国癌症防治杂志, 2021, 13(5): 477-483.
|
| [54] |
Donadon M, Lanza E, Branciforte B, et al. Hepatic uptake index in the hepatobiliary phase of gadolinium ethoxybenzyl diethylenetriamine penta acetic acid-enhanced magnetic resonance imaging estimates functional liver reserve and predicts post-hepatectomy liver failure[J]. Surgery, 2020, 168(3): 419-425.
|
| [55] |
Notake T, Shimizu A, Kubota K, et al. Hepatocellular uptake index obtained with gadoxetate disodium-enhanced magnetic resonance imaging in the assessment future liver remnant function after major hepatectomy for biliary malignancy[J]. BJS Open, 2021, 5(4): zraa048.
|
| [56] |
刘爱民, 谭邦国, 卢福麟, 等. 钆塞酸二钠增强MRI预测乙型肝炎肝硬化合并肝细胞癌切除术后肝功能不全的研究[J]. 川北医学院学报, 2022, 37(2): 153-157.
|
| [57] |
Huang M, Shen S, Cai H, et al. Regional liver function analysis with gadoxetic acid-enhanced MRI and virtual hepatectomy: prediction of postoperative short-term outcomes for HCC[J]. Eur Radiol, 2021, 31(7): 4720-4730.
|
| [58] |
Wang Y, Zhang L, Ning J, et al. Preoperative Remnant Liver Function Evaluation Using a Routine Clinical Dynamic Gd-EOB-DTPA-Enhanced MRI Protocol in Patients with Hepatocellular Carcinoma[J]. Ann Surg Oncol, 2021, 28(7): 3672-3682.
|
| [59] |
Kim DK, Choi JI, Choi M H, et al. Prediction of Posthepatectomy Liver Failure: MRI With Hepatocyte-Specific Contrast Agent Versus Indocyanine Green Clearance Test[J]. AJR Am J Roentgenol, 2018, 211(3): 580-587.
|
| [60] |
Bastati N, Beer L, Mandorfer M, et al. Does the Functional Liver Imaging Score Derived from Gadoxetic Acid-enhanced MRI Predict Outcomes in Chronic Liver Disease?[J]. Radiology, 2020, 294(1): 98-107.
|
| [61] |
Luo N, Huang X, Ji Y, et al. A functional liver imaging score for preoperative prediction of liver failure after hepatocellular carcinoma resection[J]. Eur Radiol, 2022, 32(8): 5623-5632.
|
| [62] |
Bastati N, Beer L, Ba-Ssalamah A, et al. Gadoxetic acid-enhanced MRI-derived functional liver imaging score(FLIS) and spleen diameter predict outcomes in ACLD[J]. J Hepatol, 2022, 77(4): 1005-1013.
|